Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update
Immunome shares fell 5.3% to $19.72 in late trading Monday, underperforming biotech indexes and dropping below December’s $21.50 offering price. About 1.6 million shares changed hands by 3:54 p.m. EST. The company’s next update is expected at the J.P. Morgan Healthcare Conference on Jan. 14. No new company news has been released since December 16.